Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Urogynecology Journal
Erschienen in: International Urogynecology Journal 3/2011

01.03.2011 | Original Article

Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse

verfasst von: Zeelha Abdool, Ranee Thakar, Abdul H. Sultan, Reeba S. Oliver

Erschienen in: International Urogynecology Journal | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The aim of this study is to evaluate and compare the effectiveness of pessaries and surgery in women with symptomatic pelvic organ prolapse.

Methods

A total of 554 women with symptomatic pelvic organ prolapse (POP) were recruited and treated with either a vaginal pessary (n = 359) or surgery (n = 195). Using the validated Sheffield POP questionnaire, outcomes were evaluated and then compared at 1 year.

Results

At 1 year, the only significant difference between the two groups was increased frequency of intercourse in the surgery group (54% vs 46%; p = 0.028), which was not significant when controlled for age. There was a statistically significant improvement in prolapse, urinary, bowel, and sexual function in both pessary users and those treated surgically.

Conclusions

One year after treatment, women with POP report similar improvement in urinary, bowel, sexual function, and quality of life parameters when treated with pessary or surgical correction.
Literatur
1.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed
2.
Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V (2005) The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG 112:971–976CrossRefPubMed
3.
Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL (2004) Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 190:1025–1029CrossRefPubMed
4.
Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW (2006) Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol 108:93–99CrossRefPubMed
5.
Komesu YM, Rogers RG, Rode MA, Craig EC, Gallegos KA, Montoya AR et al (2007) Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol 197:620.e1–620.e6CrossRef
6.
Kuhn A, Bapst D, Stadlmayr W, Vits C, Mueller M (2009) Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful? Ferti Steril 5:1914–1918CrossRef
7.
Adams EJ, Thomson AJM, Maher C, Hagen S (2004) Mechanical devices for pelvic organ prolapse in women. Cochrane Database Syst Rev (2):CD004010
8.
9.
Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98:646–651CrossRefPubMed
10.
11.
Kapoor DS, Thakar R, Sultan AH, Oliver R (2009) Conservative versus surgical managment of prolapse: What dictates patient choice? Int Urogynecol J Pelvic Floor Dycfunct 20:1157–1161CrossRef
12.
Bradshaw HD, Hiller L, Farkas AG, Radley S, Radley SC (2006) Development and psychometric testing of a symptom index for pelvic organ prolapse. J Obstet Gynaecol 26:241–252CrossRefPubMed
13.
Baden WF, Walker T (1992) Surgical repair of vaginal wall defects. Lippincott, Philadelphia
14.
Powers K, Lazarou G, Wang A, La Combe J, Besinger G, Greston WM et al (2006) Pessary use in advanced pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 17:160–164CrossRefPubMed
15.
Hullfish KL, Bovbjerg VE, Gurka MJ, Steers WD (2008) Surgical versus nonsurgical treatment of women with pelvic floor dysfunction: patient centered goals at 1 year. J Urol 179:2280–2285CrossRefPubMed
16.
Hullfish KL, Bovbjerg VE, Steers WD (2007) Colpocleisis for pelvic organ prolapse: patient goals, quality of life, and satisfaction. Obstet Gynecol 110:341–345CrossRefPubMed
17.
Schaffer J, Cundiff GW, Amundsen CL, Bent A, Coates KW, Strohbehn K et al (2006) Do pessaries improve lower urinary tract symptoms? J Pelvic Med Surg 12:72–73CrossRef
18.
Fourth International Consultation on Incontinence (ICI)—5–8 July 2008, Palais des Congres, Paris, France
19.
Clark AL, Gregory T, Smith VJ, Edwards R (2003) Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 189:1261–1267CrossRefPubMed
20.
Fialkow M, Symons RG, Flum D (2008) Reoperation for urinary incontinence. Am J Obstet Gynecol 199:546.e1–546.e8CrossRef
21.
Fialkow MF, Newton KM, Weiss NS (2008) Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct 19:1483–1487CrossRefPubMed
22.
Vakili B, Zheng YT, Loesch H, Echols KT, Franco N, Chesson RR (2005) Levator contraction strength and genital hiatus as risk factors for recurrent pelvic organ prolapse. Am J Obstet Gynecol 192:1592–1598CrossRefPubMed
23.
Wiskind AK, Creighton SM, Stanton SL (1992) The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol 167:399–404PubMed
24.
Kjolhede P, Noren B, Ryden G (1996) Prediction of genital prolapse after Burch colposuspension. Acta Obstet Gynecol Scand 75:849–854CrossRefPubMed
25.
Lambrou NC, Buller JL, Thompson JR, Cundiff GW, Chou B, Montz FJ (2000) Prevalence of perioperative complications among women undergoing reconstructive pelvic surgery. Am J Obstet Gynecol 183:1355–1358CrossRefPubMed
26.
Stepp KJ, Barber MD, Yoo EH, Whiteside JL, Paraiso MF, Walters MD (2005) Incidence of perioperative complications of urogynecologic surgery in elderly women. Am J Obstet Gynecol 192:1630–1636CrossRefPubMed
27.
Sung VW, Weitzen S, Sokol ER, Rardin CR, Myers DL (2006) Effect of patient age on increasing morbidity and mortality following urogynecologic surgery. Am J Obstet Gynecol 194:1411–1417CrossRefPubMed
Metadaten
Titel
Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse
verfasst von
Zeelha Abdool
Ranee Thakar
Abdul H. Sultan
Reeba S. Oliver
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 3/2011
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-010-1340-9

Weitere Artikel der Ausgabe 3/2011

International Urogynecology Journal 3/2011 Zur Ausgabe

Original Article

Outcome of tension-free obturator tape procedures in obese and overweight women

Original Article

Combined anterior trans-obturator mesh and sacrospinous ligament fixation in women with severe prolapse—a case series of 30 months follow-up

Original Article

Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence

Letter to the Editor

Measuring the effect of antimuscarinics in the bladder

Original Article

Pubococcygeal activity on perineal ultrasound in incontinent women

Original Article

What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence—a multi-centre randomised controlled trial

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise